| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Tetracycline hydrochloride |
Is a |
False |
Tetracycline (substance) |
Inferred relationship |
Some |
|
| Tyrothricin |
Is a |
False |
Tetracycline (substance) |
Inferred relationship |
Some |
|
| Meclocycline |
Is a |
False |
Tetracycline (substance) |
Inferred relationship |
Some |
|
| Tetracycline phosphate complex |
Is a |
False |
Tetracycline (substance) |
Inferred relationship |
Some |
|
| Tetracycline measurement |
Component |
True |
Tetracycline (substance) |
Inferred relationship |
Some |
1 |
| Pill oesophagitis caused by tetracycline |
Causative agent (attribute) |
False |
Tetracycline (substance) |
Inferred relationship |
Some |
2 |
| Tetracycline poisoning |
Causative agent (attribute) |
True |
Tetracycline (substance) |
Inferred relationship |
Some |
1 |
| Accidental tetracycline poisoning |
Causative agent (attribute) |
False |
Tetracycline (substance) |
Inferred relationship |
Some |
|
| Intentional tetracycline poisoning |
Causative agent (attribute) |
False |
Tetracycline (substance) |
Inferred relationship |
Some |
|
| intoxication par la tétracycline d'intention indéterminée |
Causative agent (attribute) |
False |
Tetracycline (substance) |
Inferred relationship |
Some |
1 |
| Tetracycline adverse reaction |
Causative agent (attribute) |
True |
Tetracycline (substance) |
Inferred relationship |
Some |
1 |
| Allergy to tetracycline (finding) |
Causative agent (attribute) |
False |
Tetracycline (substance) |
Inferred relationship |
Some |
|
| Tetracycline overdose |
Causative agent (attribute) |
True |
Tetracycline (substance) |
Inferred relationship |
Some |
1 |
| Accidental tetracycline overdose |
Causative agent (attribute) |
True |
Tetracycline (substance) |
Inferred relationship |
Some |
1 |
| Intentional tetracycline overdose |
Causative agent (attribute) |
True |
Tetracycline (substance) |
Inferred relationship |
Some |
1 |
| surdose de tétracycline d'intention indéterminée |
Causative agent (attribute) |
False |
Tetracycline (substance) |
Inferred relationship |
Some |
1 |
| Tetracyclines [systemic] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracycline (substance) |
Inferred relationship |
Some |
|
| Tetracycline [systemic] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracycline (substance) |
Inferred relationship |
Some |
|
| Product containing precisely tetracycline 250 milligram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracycline (substance) |
Inferred relationship |
Some |
|
| Product containing precisely tetracycline 250 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracycline (substance) |
Inferred relationship |
Some |
|
| Tetracycline for oropharynx |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracycline (substance) |
Inferred relationship |
Some |
|
| Tetracycline [mouth-no drugs here] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracycline (substance) |
Inferred relationship |
Some |
|
| Tetracyclines [skin] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracycline (substance) |
Inferred relationship |
Some |
|
| Product containing tetracycline in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tetracycline (substance) |
Inferred relationship |
Some |
1 |
| Product containing tetracycline in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tetracycline (substance) |
Inferred relationship |
Some |
1 |
| Product containing tetracycline in topical dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracycline (substance) |
Inferred relationship |
Some |
|
| Tetracycline 100 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracycline (substance) |
Inferred relationship |
Some |
|
| Tetracycline 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracycline (substance) |
Inferred relationship |
Some |
|
| Tetracycline 25 mg/mL oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracycline (substance) |
Inferred relationship |
Some |
|
| Bismuth subsalicylate+metronidazole+tetracycline hydrochloride 262.4 mg/250 mg/500 mg kit |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracycline (substance) |
Inferred relationship |
Some |
|
| Product containing precisely tetracycline 500 milligram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracycline (substance) |
Inferred relationship |
Some |
|
| Tetracycline 125mg/5mL syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracycline (substance) |
Inferred relationship |
Some |
|
| Lymecycline (substance) |
Is a |
False |
Tetracycline (substance) |
Inferred relationship |
Some |
|
| Pleurodesis with tetracycline |
Direct substance |
False |
Tetracycline (substance) |
Inferred relationship |
Some |
1 |
| Posteruptive tooth staining caused by tetracycline (disorder) |
Causative agent (attribute) |
False |
Tetracycline (substance) |
Inferred relationship |
Some |
3 |
| Product containing tetracycline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tetracycline (substance) |
Inferred relationship |
Some |
1 |
| Product containing procaine and tetracycline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tetracycline (substance) |
Inferred relationship |
Some |
1 |
| Product containing nystatin and tetracycline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tetracycline (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely benzocaine 5 milligram and tyrothricin 1 milligram/1 each conventional release oromucosal lozenge (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracycline (substance) |
Inferred relationship |
Some |
|
| Product containing tyrothricin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracycline (substance) |
Inferred relationship |
Some |
|
| Adverse reaction to tetracycline NOS |
Causative agent (attribute) |
False |
Tetracycline (substance) |
Inferred relationship |
Some |
|
| Product containing bismuth subsalicylate and metronidazole and tetracycline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tetracycline (substance) |
Inferred relationship |
Some |
2 |
| Accidental tetracycline poisoning |
Causative agent (attribute) |
True |
Tetracycline (substance) |
Inferred relationship |
Some |
1 |
| Intentional tetracycline poisoning |
Causative agent (attribute) |
True |
Tetracycline (substance) |
Inferred relationship |
Some |
1 |
| Product containing tetracycline in ophthalmic dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracycline (substance) |
Inferred relationship |
Some |
|
| Product containing bismuth subcitrate potassium and metronidazole and tetracycline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tetracycline (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracycline (substance) |
Inferred relationship |
Some |
|
| Pleurodesis with tetracycline |
Direct substance |
False |
Tetracycline (substance) |
Inferred relationship |
Some |
1 |
| Pleurodesis with tetracycline |
Using substance (attribute) |
True |
Tetracycline (substance) |
Inferred relationship |
Some |
1 |
| Product containing amphotericin and tetracycline |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracycline (substance) |
Inferred relationship |
Some |
2 |
| Pleurodesis with tetracycline |
Using substance (attribute) |
False |
Tetracycline (substance) |
Inferred relationship |
Some |
1 |
| Allergy to tetracycline (finding) |
Causative agent (attribute) |
True |
Tetracycline (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely tetracycline 250 milligram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracycline (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely tetracycline 250 milligram/1 each conventional release oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Tetracycline (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely tetracycline 250 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracycline (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely tetracycline 250 milligram/1 each conventional release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Tetracycline (substance) |
Inferred relationship |
Some |
1 |
| Tetracycline 100 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracycline (substance) |
Inferred relationship |
Some |
1 |
| Tetracycline 100 mg oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Tetracycline (substance) |
Inferred relationship |
Some |
1 |
| Tetracycline 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracycline (substance) |
Inferred relationship |
Some |
1 |
| Tetracycline 500 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Tetracycline (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely tetracycline 500 milligram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracycline (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely tetracycline 500 milligram/1 each conventional release oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Tetracycline (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Tetracycline (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracycline (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Tetracycline (substance) |
Inferred relationship |
Some |
2 |
| Tetracycline hydrochloride |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Tetracycline (substance) |
Inferred relationship |
Some |
|
| Tetracycline phosphate complex |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Tetracycline (substance) |
Inferred relationship |
Some |
|
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Tetracycline (substance) |
Inferred relationship |
Some |
1 |
| Product containing bismuth subcitrate potassium and metronidazole and tetracycline in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tetracycline (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely tetracycline 250 milligram/1 each conventional release oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Tetracycline (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely tetracycline 250 milligram/1 each conventional release oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Tetracycline (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely tetracycline 500 milligram/1 each conventional release oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Tetracycline (substance) |
Inferred relationship |
Some |
1 |
| Tetracycline 100 mg oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Tetracycline (substance) |
Inferred relationship |
Some |
1 |
| Tetracycline 500 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Tetracycline (substance) |
Inferred relationship |
Some |
1 |
| Tetracycline-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tetracycline (substance) |
Inferred relationship |
Some |
1 |
| Product containing tetracycline in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tetracycline (substance) |
Inferred relationship |
Some |
1 |
| Product containing only amphotericin and tetracycline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracycline (substance) |
Inferred relationship |
Some |
2 |
| Product containing only bismuth subsalicylate and metronidazole and tetracycline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tetracycline (substance) |
Inferred relationship |
Some |
2 |
| Product containing only bismuth subcitrate potassium and metronidazole and tetracycline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tetracycline (substance) |
Inferred relationship |
Some |
2 |
| Product containing only nystatin and tetracycline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tetracycline (substance) |
Inferred relationship |
Some |
1 |
| Tetracycline only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tetracycline (substance) |
Inferred relationship |
Some |
1 |
| Product containing only procaine and tetracycline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tetracycline (substance) |
Inferred relationship |
Some |
1 |
| Product containing only bismuth subcitrate potassium and metronidazole and tetracycline in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tetracycline (substance) |
Inferred relationship |
Some |
2 |
| Product containing only tetracycline in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tetracycline (substance) |
Inferred relationship |
Some |
1 |
| Product containing only tetracycline in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tetracycline (substance) |
Inferred relationship |
Some |
1 |
| Tetracycline only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tetracycline (substance) |
Inferred relationship |
Some |
1 |
| Tetracycline only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Tetracycline (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely tetracycline (as tetracycline hydrochloride) 250 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Tetracycline (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely tetracycline (as tetracycline hydrochloride) 250 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Tetracycline (substance) |
Inferred relationship |
Some |
1 |
| Tetracycline 25 mg/mL oral suspension |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Tetracycline (substance) |
Inferred relationship |
Some |
1 |
| Tetracycline 25 mg/mL oral suspension |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Tetracycline (substance) |
Inferred relationship |
Some |
1 |
| Tetracycline 10 mg/g cutaneous ointment |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Tetracycline (substance) |
Inferred relationship |
Some |
1 |
| Tetracycline 10 mg/g cutaneous ointment |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Tetracycline (substance) |
Inferred relationship |
Some |
1 |
| Tetracycline 10 mg/mL cutaneous lotion |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Tetracycline (substance) |
Inferred relationship |
Some |
1 |
| Tetracycline 10 mg/mL cutaneous lotion |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Tetracycline (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely tetracycline 25 milligram/1 milliliter conventional release oral solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Tetracycline (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely tetracycline 25 milligram/1 milliliter conventional release oral solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Tetracycline (substance) |
Inferred relationship |
Some |
1 |
| Pill oesophagitis caused by tetracycline |
Causative agent (attribute) |
True |
Tetracycline (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Tetracycline (substance) |
Inferred relationship |
Some |
2 |
| Intrinsic staining of tooth caused by tetracycline |
Causative agent (attribute) |
True |
Tetracycline (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely tetracycline (as lymecycline) 300 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Tetracycline (substance) |
Inferred relationship |
Some |
1 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]